ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $24.21 Average PT from Brokerages
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven research firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target […]
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven research firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target […]
